nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN1A—Topiramate—obesity	0.354	0.594	CbGbCtD
Mepivacaine—SCN5A—Topiramate—obesity	0.242	0.406	CbGbCtD
Mepivacaine—Block heart—Cimetidine—obesity	0.00871	0.0259	CcSEcCtD
Mepivacaine—SCN8A—hindbrain—obesity	0.00721	0.143	CbGeAlD
Mepivacaine—Paraesthesia oral—Sibutramine—obesity	0.00563	0.0167	CcSEcCtD
Mepivacaine—SCN1A—hindbrain—obesity	0.00545	0.108	CbGeAlD
Mepivacaine—Atrioventricular block—Cimetidine—obesity	0.0051	0.0151	CcSEcCtD
Mepivacaine—SCN2A—hindbrain—obesity	0.005	0.099	CbGeAlD
Mepivacaine—Paraesthesia oral—Bupropion—obesity	0.00491	0.0146	CcSEcCtD
Mepivacaine—Urinary retention—Phenylpropanolamine—obesity	0.00431	0.0128	CcSEcCtD
Mepivacaine—Sweating—Benzphetamine—obesity	0.0043	0.0128	CcSEcCtD
Mepivacaine—Sneezing—Bupropion—obesity	0.00416	0.0123	CcSEcCtD
Mepivacaine—Cardiac arrest—Phentermine—obesity	0.00412	0.0122	CcSEcCtD
Mepivacaine—Sweating—Phendimetrazine—obesity	0.00392	0.0116	CcSEcCtD
Mepivacaine—Drowsiness—Phenylpropanolamine—obesity	0.00349	0.0104	CcSEcCtD
Mepivacaine—Urinary retention—Cimetidine—obesity	0.00341	0.0101	CcSEcCtD
Mepivacaine—Tremor—Methamphetamine—obesity	0.0034	0.0101	CcSEcCtD
Mepivacaine—Agitation—Methamphetamine—obesity	0.00334	0.00991	CcSEcCtD
Mepivacaine—Tremor—Benzphetamine—obesity	0.00328	0.00974	CcSEcCtD
Mepivacaine—Agitation—Benzphetamine—obesity	0.00322	0.00956	CcSEcCtD
Mepivacaine—Sweating increased—Diethylpropion—obesity	0.00317	0.00942	CcSEcCtD
Mepivacaine—Paraesthesia oral—Topiramate—obesity	0.00313	0.00929	CcSEcCtD
Mepivacaine—Apnoea—Sibutramine—obesity	0.00312	0.00925	CcSEcCtD
Mepivacaine—Vision blurred—Phendimetrazine—obesity	0.00301	0.00893	CcSEcCtD
Mepivacaine—Tremor—Phendimetrazine—obesity	0.00299	0.00888	CcSEcCtD
Mepivacaine—Agitation—Phendimetrazine—obesity	0.00293	0.00871	CcSEcCtD
Mepivacaine—Drowsiness—Diethylpropion—obesity	0.00291	0.00863	CcSEcCtD
Mepivacaine—Tachycardia—Methamphetamine—obesity	0.00289	0.00859	CcSEcCtD
Mepivacaine—Tachycardia—Benzphetamine—obesity	0.00279	0.00828	CcSEcCtD
Mepivacaine—Drowsiness—Cimetidine—obesity	0.00276	0.00821	CcSEcCtD
Mepivacaine—Hyperhidrosis—Benzphetamine—obesity	0.00276	0.00821	CcSEcCtD
Mepivacaine—Tension—Phenylpropanolamine—obesity	0.00268	0.00795	CcSEcCtD
Mepivacaine—Nervousness—Phenylpropanolamine—obesity	0.00265	0.00786	CcSEcCtD
Mepivacaine—Acidosis—Topiramate—obesity	0.00265	0.00786	CcSEcCtD
Mepivacaine—SCN9A—pituitary gland—obesity	0.00262	0.0519	CbGeAlD
Mepivacaine—SCN9A—adipose tissue—obesity	0.00261	0.0517	CbGeAlD
Mepivacaine—Vision blurred—Phenylpropanolamine—obesity	0.00257	0.00763	CcSEcCtD
Mepivacaine—Tension—Phentermine—obesity	0.00256	0.0076	CcSEcCtD
Mepivacaine—Tremor—Phenylpropanolamine—obesity	0.00256	0.00759	CcSEcCtD
Mepivacaine—Urinary incontinence—Sibutramine—obesity	0.00255	0.00757	CcSEcCtD
Mepivacaine—Tachycardia—Phendimetrazine—obesity	0.00254	0.00755	CcSEcCtD
Mepivacaine—Nervousness—Phentermine—obesity	0.00253	0.00753	CcSEcCtD
Mepivacaine—Bradycardia—Cimetidine—obesity	0.00253	0.0075	CcSEcCtD
Mepivacaine—Hyperhidrosis—Phendimetrazine—obesity	0.00252	0.00748	CcSEcCtD
Mepivacaine—Agitation—Phenylpropanolamine—obesity	0.00251	0.00744	CcSEcCtD
Mepivacaine—Tremor—Phentermine—obesity	0.00245	0.00726	CcSEcCtD
Mepivacaine—Agitation—Phentermine—obesity	0.0024	0.00712	CcSEcCtD
Mepivacaine—Urticaria—Methamphetamine—obesity	0.00236	0.00699	CcSEcCtD
Mepivacaine—SCN9A—adrenal gland—obesity	0.00234	0.0464	CbGeAlD
Mepivacaine—SCN4A—pituitary gland—obesity	0.00234	0.0463	CbGeAlD
Mepivacaine—SCN4A—adipose tissue—obesity	0.00233	0.0461	CbGeAlD
Mepivacaine—Anxiety—Phenylpropanolamine—obesity	0.00231	0.00687	CcSEcCtD
Mepivacaine—SCN8A—endocrine gland—obesity	0.00231	0.0458	CbGeAlD
Mepivacaine—Urticaria—Benzphetamine—obesity	0.00227	0.00674	CcSEcCtD
Mepivacaine—Erythema—Diethylpropion—obesity	0.00227	0.00674	CcSEcCtD
Mepivacaine—Hypertension—Phentermine—obesity	0.00225	0.00669	CcSEcCtD
Mepivacaine—Tension—Diethylpropion—obesity	0.00223	0.00662	CcSEcCtD
Mepivacaine—Urinary incontinence—Bupropion—obesity	0.00222	0.0066	CcSEcCtD
Mepivacaine—Nervousness—Diethylpropion—obesity	0.00221	0.00655	CcSEcCtD
Mepivacaine—Hypersensitivity—Methamphetamine—obesity	0.00218	0.00649	CcSEcCtD
Mepivacaine—Tachycardia—Phenylpropanolamine—obesity	0.00217	0.00645	CcSEcCtD
Mepivacaine—Vision blurred—Diethylpropion—obesity	0.00214	0.00635	CcSEcCtD
Mepivacaine—Oedema—Phentermine—obesity	0.00213	0.00632	CcSEcCtD
Mepivacaine—Tremor—Diethylpropion—obesity	0.00213	0.00632	CcSEcCtD
Mepivacaine—Hypersensitivity—Benzphetamine—obesity	0.00211	0.00625	CcSEcCtD
Mepivacaine—SCN4A—adrenal gland—obesity	0.00209	0.0414	CbGeAlD
Mepivacaine—Agitation—Diethylpropion—obesity	0.00209	0.00619	CcSEcCtD
Mepivacaine—Hypotension—Phenylpropanolamine—obesity	0.00208	0.00618	CcSEcCtD
Mepivacaine—Tachycardia—Phentermine—obesity	0.00208	0.00617	CcSEcCtD
Mepivacaine—SCN2A—pituitary gland—obesity	0.00207	0.041	CbGeAlD
Mepivacaine—SCN5A—cardiovascular system—obesity	0.00205	0.0406	CbGeAlD
Mepivacaine—SCN10A—pituitary gland—obesity	0.002	0.0395	CbGeAlD
Mepivacaine—Agitation—Cimetidine—obesity	0.00199	0.00589	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Sibutramine—obesity	0.00198	0.00588	CcSEcCtD
Mepivacaine—Somnolence—Phenylpropanolamine—obesity	0.00198	0.00588	CcSEcCtD
Mepivacaine—Convulsion—Diethylpropion—obesity	0.00197	0.00584	CcSEcCtD
Mepivacaine—Dizziness—Methamphetamine—obesity	0.00196	0.00582	CcSEcCtD
Mepivacaine—Anxiety—Diethylpropion—obesity	0.00193	0.00572	CcSEcCtD
Mepivacaine—Dizziness—Benzphetamine—obesity	0.00189	0.00561	CcSEcCtD
Mepivacaine—Headache—Methamphetamine—obesity	0.00186	0.00551	CcSEcCtD
Mepivacaine—Anxiety—Cimetidine—obesity	0.00183	0.00544	CcSEcCtD
Mepivacaine—Urinary retention—Sibutramine—obesity	0.00182	0.00541	CcSEcCtD
Mepivacaine—Cardiac arrest—Sibutramine—obesity	0.00182	0.00541	CcSEcCtD
Mepivacaine—SCN3A—pituitary gland—obesity	0.00182	0.036	CbGeAlD
Mepivacaine—SCN3A—adipose tissue—obesity	0.00181	0.0359	CbGeAlD
Mepivacaine—Tachycardia—Diethylpropion—obesity	0.00181	0.00537	CcSEcCtD
Mepivacaine—Hyperhidrosis—Diethylpropion—obesity	0.00179	0.00532	CcSEcCtD
Mepivacaine—Headache—Benzphetamine—obesity	0.00179	0.00532	CcSEcCtD
Mepivacaine—Anaphylactic shock—Cimetidine—obesity	0.00176	0.00523	CcSEcCtD
Mepivacaine—Dizziness—Phendimetrazine—obesity	0.00172	0.00512	CcSEcCtD
Mepivacaine—Tachycardia—Cimetidine—obesity	0.00172	0.00511	CcSEcCtD
Mepivacaine—SCN5A—digestive system—obesity	0.0017	0.0337	CbGeAlD
Mepivacaine—Nausea—Benzphetamine—obesity	0.0017	0.00504	CcSEcCtD
Mepivacaine—Urticaria—Phentermine—obesity	0.00169	0.00502	CcSEcCtD
Mepivacaine—Sweating increased—Orlistat—obesity	0.00167	0.00495	CcSEcCtD
Mepivacaine—Somnolence—Diethylpropion—obesity	0.00165	0.00489	CcSEcCtD
Mepivacaine—Hypersensitivity—Phenylpropanolamine—obesity	0.00164	0.00487	CcSEcCtD
Mepivacaine—Headache—Phendimetrazine—obesity	0.00163	0.00485	CcSEcCtD
Mepivacaine—SCN3A—adrenal gland—obesity	0.00163	0.0322	CbGeAlD
Mepivacaine—SCN2A—endocrine gland—obesity	0.00161	0.0317	CbGeAlD
Mepivacaine—Urinary retention—Bupropion—obesity	0.00159	0.00472	CcSEcCtD
Mepivacaine—Somnolence—Cimetidine—obesity	0.00157	0.00465	CcSEcCtD
Mepivacaine—Nausea—Phendimetrazine—obesity	0.00155	0.0046	CcSEcCtD
Mepivacaine—SCN10A—endocrine gland—obesity	0.00155	0.0306	CbGeAlD
Mepivacaine—Asthenia—Phentermine—obesity	0.00153	0.00454	CcSEcCtD
Mepivacaine—Atrioventricular block—Topiramate—obesity	0.00151	0.00449	CcSEcCtD
Mepivacaine—Urticaria—Diethylpropion—obesity	0.00147	0.00437	CcSEcCtD
Mepivacaine—Dizziness—Phenylpropanolamine—obesity	0.00147	0.00437	CcSEcCtD
Mepivacaine—Urinary incontinence—Topiramate—obesity	0.00142	0.0042	CcSEcCtD
Mepivacaine—Sweating—Sibutramine—obesity	0.00142	0.0042	CcSEcCtD
Mepivacaine—Vomiting—Phenylpropanolamine—obesity	0.00142	0.0042	CcSEcCtD
Mepivacaine—Dizziness—Phentermine—obesity	0.00141	0.00418	CcSEcCtD
Mepivacaine—Sweating increased—Bupropion—obesity	0.00141	0.00418	CcSEcCtD
Mepivacaine—Body temperature increased—Cimetidine—obesity	0.00139	0.00414	CcSEcCtD
Mepivacaine—Vomiting—Phentermine—obesity	0.00135	0.00402	CcSEcCtD
Mepivacaine—Bradycardia—Sibutramine—obesity	0.00135	0.00401	CcSEcCtD
Mepivacaine—Headache—Phentermine—obesity	0.00133	0.00396	CcSEcCtD
Mepivacaine—Nausea—Phenylpropanolamine—obesity	0.00132	0.00393	CcSEcCtD
Mepivacaine—Hypersensitivity—Cimetidine—obesity	0.0013	0.00386	CcSEcCtD
Mepivacaine—Nausea—Phentermine—obesity	0.00127	0.00376	CcSEcCtD
Mepivacaine—Asthenia—Cimetidine—obesity	0.00127	0.00376	CcSEcCtD
Mepivacaine—Tinnitus—Sibutramine—obesity	0.00124	0.00367	CcSEcCtD
Mepivacaine—Sweating—Bupropion—obesity	0.00123	0.00367	CcSEcCtD
Mepivacaine—Dizziness—Diethylpropion—obesity	0.00123	0.00364	CcSEcCtD
Mepivacaine—Chills—Sibutramine—obesity	0.00119	0.00353	CcSEcCtD
Mepivacaine—Vomiting—Diethylpropion—obesity	0.00118	0.0035	CcSEcCtD
Mepivacaine—Dizziness—Cimetidine—obesity	0.00117	0.00346	CcSEcCtD
Mepivacaine—Headache—Diethylpropion—obesity	0.00116	0.00345	CcSEcCtD
Mepivacaine—Back pain—Orlistat—obesity	0.00115	0.00343	CcSEcCtD
Mepivacaine—Tension—Sibutramine—obesity	0.00113	0.00336	CcSEcCtD
Mepivacaine—Vision blurred—Orlistat—obesity	0.00112	0.00334	CcSEcCtD
Mepivacaine—Nervousness—Sibutramine—obesity	0.00112	0.00333	CcSEcCtD
Mepivacaine—Vomiting—Cimetidine—obesity	0.00112	0.00333	CcSEcCtD
Mepivacaine—Back pain—Sibutramine—obesity	0.00112	0.00332	CcSEcCtD
Mepivacaine—Headache—Cimetidine—obesity	0.0011	0.00328	CcSEcCtD
Mepivacaine—Nausea—Diethylpropion—obesity	0.0011	0.00327	CcSEcCtD
Mepivacaine—Angioedema—Orlistat—obesity	0.00109	0.00324	CcSEcCtD
Mepivacaine—Vision blurred—Sibutramine—obesity	0.00109	0.00323	CcSEcCtD
Mepivacaine—Tremor—Sibutramine—obesity	0.00108	0.00321	CcSEcCtD
Mepivacaine—Tinnitus—Bupropion—obesity	0.00108	0.0032	CcSEcCtD
Mepivacaine—Agitation—Sibutramine—obesity	0.00106	0.00315	CcSEcCtD
Mepivacaine—Angioedema—Sibutramine—obesity	0.00105	0.00313	CcSEcCtD
Mepivacaine—Nausea—Cimetidine—obesity	0.00105	0.00311	CcSEcCtD
Mepivacaine—Chills—Bupropion—obesity	0.00104	0.00308	CcSEcCtD
Mepivacaine—Syncope—Sibutramine—obesity	0.00104	0.00307	CcSEcCtD
Mepivacaine—Convulsion—Orlistat—obesity	0.00103	0.00307	CcSEcCtD
Mepivacaine—Loss of consciousness—Sibutramine—obesity	0.00101	0.00301	CcSEcCtD
Mepivacaine—Urinary retention—Topiramate—obesity	0.00101	0.00301	CcSEcCtD
Mepivacaine—Anxiety—Orlistat—obesity	0.00101	0.003	CcSEcCtD
Mepivacaine—Convulsion—Sibutramine—obesity	0.001	0.00297	CcSEcCtD
Mepivacaine—Hypertension—Sibutramine—obesity	0.000997	0.00296	CcSEcCtD
Mepivacaine—Tension—Bupropion—obesity	0.000988	0.00293	CcSEcCtD
Mepivacaine—Anxiety—Sibutramine—obesity	0.000979	0.00291	CcSEcCtD
Mepivacaine—Nervousness—Bupropion—obesity	0.000977	0.0029	CcSEcCtD
Mepivacaine—Anaphylactic shock—Orlistat—obesity	0.000973	0.00289	CcSEcCtD
Mepivacaine—Oedema—Orlistat—obesity	0.000973	0.00289	CcSEcCtD
Mepivacaine—Back pain—Bupropion—obesity	0.000973	0.00289	CcSEcCtD
Mepivacaine—Vision blurred—Bupropion—obesity	0.000948	0.00282	CcSEcCtD
Mepivacaine—Tremor—Bupropion—obesity	0.000943	0.0028	CcSEcCtD
Mepivacaine—Oedema—Sibutramine—obesity	0.000942	0.0028	CcSEcCtD
Mepivacaine—Anaphylactic shock—Sibutramine—obesity	0.000942	0.0028	CcSEcCtD
Mepivacaine—Hyperhidrosis—Orlistat—obesity	0.000941	0.00279	CcSEcCtD
Mepivacaine—Shock—Sibutramine—obesity	0.000927	0.00275	CcSEcCtD
Mepivacaine—Agitation—Bupropion—obesity	0.000925	0.00275	CcSEcCtD
Mepivacaine—Angioedema—Bupropion—obesity	0.00092	0.00273	CcSEcCtD
Mepivacaine—Tachycardia—Sibutramine—obesity	0.000919	0.00273	CcSEcCtD
Mepivacaine—Hyperhidrosis—Sibutramine—obesity	0.000911	0.0027	CcSEcCtD
Mepivacaine—Syncope—Bupropion—obesity	0.000902	0.00268	CcSEcCtD
Mepivacaine—Sweating increased—Topiramate—obesity	0.000896	0.00266	CcSEcCtD
Mepivacaine—Loss of consciousness—Bupropion—obesity	0.000884	0.00263	CcSEcCtD
Mepivacaine—Hypotension—Sibutramine—obesity	0.00088	0.00261	CcSEcCtD
Mepivacaine—Paraesthesia—Orlistat—obesity	0.000874	0.0026	CcSEcCtD
Mepivacaine—Convulsion—Bupropion—obesity	0.000872	0.00259	CcSEcCtD
Mepivacaine—Hypertension—Bupropion—obesity	0.000869	0.00258	CcSEcCtD
Mepivacaine—Anxiety—Bupropion—obesity	0.000854	0.00253	CcSEcCtD
Mepivacaine—Paraesthesia—Sibutramine—obesity	0.000846	0.00251	CcSEcCtD
Mepivacaine—Somnolence—Sibutramine—obesity	0.000838	0.00249	CcSEcCtD
Mepivacaine—Anaphylactic shock—Bupropion—obesity	0.000821	0.00244	CcSEcCtD
Mepivacaine—Oedema—Bupropion—obesity	0.000821	0.00244	CcSEcCtD
Mepivacaine—Shock—Bupropion—obesity	0.000808	0.0024	CcSEcCtD
Mepivacaine—Tachycardia—Bupropion—obesity	0.000802	0.00238	CcSEcCtD
Mepivacaine—Hyperhidrosis—Bupropion—obesity	0.000794	0.00236	CcSEcCtD
Mepivacaine—Urticaria—Orlistat—obesity	0.000773	0.0023	CcSEcCtD
Mepivacaine—Body temperature increased—Orlistat—obesity	0.00077	0.00228	CcSEcCtD
Mepivacaine—Hypotension—Bupropion—obesity	0.000767	0.00228	CcSEcCtD
Mepivacaine—Bradycardia—Topiramate—obesity	0.00075	0.00223	CcSEcCtD
Mepivacaine—Urticaria—Sibutramine—obesity	0.000748	0.00222	CcSEcCtD
Mepivacaine—Body temperature increased—Sibutramine—obesity	0.000745	0.00221	CcSEcCtD
Mepivacaine—Paraesthesia—Bupropion—obesity	0.000737	0.00219	CcSEcCtD
Mepivacaine—Somnolence—Bupropion—obesity	0.00073	0.00217	CcSEcCtD
Mepivacaine—Hypersensitivity—Orlistat—obesity	0.000717	0.00213	CcSEcCtD
Mepivacaine—Asthenia—Orlistat—obesity	0.000698	0.00207	CcSEcCtD
Mepivacaine—Hypersensitivity—Sibutramine—obesity	0.000694	0.00206	CcSEcCtD
Mepivacaine—Pruritus—Orlistat—obesity	0.000689	0.00204	CcSEcCtD
Mepivacaine—Tinnitus—Topiramate—obesity	0.000687	0.00204	CcSEcCtD
Mepivacaine—Asthenia—Sibutramine—obesity	0.000676	0.00201	CcSEcCtD
Mepivacaine—Pruritus—Sibutramine—obesity	0.000667	0.00198	CcSEcCtD
Mepivacaine—Chills—Topiramate—obesity	0.000661	0.00196	CcSEcCtD
Mepivacaine—Urticaria—Bupropion—obesity	0.000652	0.00194	CcSEcCtD
Mepivacaine—Body temperature increased—Bupropion—obesity	0.000649	0.00193	CcSEcCtD
Mepivacaine—Dizziness—Orlistat—obesity	0.000644	0.00191	CcSEcCtD
Mepivacaine—Erythema—Topiramate—obesity	0.000641	0.0019	CcSEcCtD
Mepivacaine—Tension—Topiramate—obesity	0.000629	0.00187	CcSEcCtD
Mepivacaine—Dizziness—Sibutramine—obesity	0.000623	0.00185	CcSEcCtD
Mepivacaine—Nervousness—Topiramate—obesity	0.000623	0.00185	CcSEcCtD
Mepivacaine—Back pain—Topiramate—obesity	0.00062	0.00184	CcSEcCtD
Mepivacaine—Vomiting—Orlistat—obesity	0.000619	0.00184	CcSEcCtD
Mepivacaine—Headache—Orlistat—obesity	0.00061	0.00181	CcSEcCtD
Mepivacaine—Hypersensitivity—Bupropion—obesity	0.000605	0.0018	CcSEcCtD
Mepivacaine—Vision blurred—Topiramate—obesity	0.000604	0.00179	CcSEcCtD
Mepivacaine—Tremor—Topiramate—obesity	0.000601	0.00178	CcSEcCtD
Mepivacaine—Vomiting—Sibutramine—obesity	0.000599	0.00178	CcSEcCtD
Mepivacaine—Headache—Sibutramine—obesity	0.00059	0.00175	CcSEcCtD
Mepivacaine—Asthenia—Bupropion—obesity	0.000589	0.00175	CcSEcCtD
Mepivacaine—Agitation—Topiramate—obesity	0.000589	0.00175	CcSEcCtD
Mepivacaine—Pruritus—Bupropion—obesity	0.000581	0.00173	CcSEcCtD
Mepivacaine—Nausea—Orlistat—obesity	0.000578	0.00172	CcSEcCtD
Mepivacaine—Syncope—Topiramate—obesity	0.000575	0.00171	CcSEcCtD
Mepivacaine—Loss of consciousness—Topiramate—obesity	0.000564	0.00167	CcSEcCtD
Mepivacaine—Nausea—Sibutramine—obesity	0.00056	0.00166	CcSEcCtD
Mepivacaine—Convulsion—Topiramate—obesity	0.000555	0.00165	CcSEcCtD
Mepivacaine—Hypertension—Topiramate—obesity	0.000554	0.00164	CcSEcCtD
Mepivacaine—Anxiety—Topiramate—obesity	0.000544	0.00161	CcSEcCtD
Mepivacaine—Dizziness—Bupropion—obesity	0.000543	0.00161	CcSEcCtD
Mepivacaine—Oedema—Topiramate—obesity	0.000523	0.00155	CcSEcCtD
Mepivacaine—Vomiting—Bupropion—obesity	0.000522	0.00155	CcSEcCtD
Mepivacaine—Shock—Topiramate—obesity	0.000515	0.00153	CcSEcCtD
Mepivacaine—Headache—Bupropion—obesity	0.000515	0.00153	CcSEcCtD
Mepivacaine—Tachycardia—Topiramate—obesity	0.000511	0.00152	CcSEcCtD
Mepivacaine—Hyperhidrosis—Topiramate—obesity	0.000506	0.0015	CcSEcCtD
Mepivacaine—Hypotension—Topiramate—obesity	0.000489	0.00145	CcSEcCtD
Mepivacaine—Nausea—Bupropion—obesity	0.000488	0.00145	CcSEcCtD
Mepivacaine—Paraesthesia—Topiramate—obesity	0.00047	0.00139	CcSEcCtD
Mepivacaine—Somnolence—Topiramate—obesity	0.000465	0.00138	CcSEcCtD
Mepivacaine—Urticaria—Topiramate—obesity	0.000416	0.00123	CcSEcCtD
Mepivacaine—Body temperature increased—Topiramate—obesity	0.000414	0.00123	CcSEcCtD
Mepivacaine—Hypersensitivity—Topiramate—obesity	0.000386	0.00114	CcSEcCtD
Mepivacaine—Asthenia—Topiramate—obesity	0.000375	0.00111	CcSEcCtD
Mepivacaine—Pruritus—Topiramate—obesity	0.00037	0.0011	CcSEcCtD
Mepivacaine—Dizziness—Topiramate—obesity	0.000346	0.00103	CcSEcCtD
Mepivacaine—Vomiting—Topiramate—obesity	0.000333	0.000988	CcSEcCtD
Mepivacaine—Headache—Topiramate—obesity	0.000328	0.000973	CcSEcCtD
Mepivacaine—Nausea—Topiramate—obesity	0.000311	0.000923	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—MYOG—obesity	7.72e-05	0.00461	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MYOD1—obesity	7.66e-05	0.00457	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SREBF2—obesity	7.6e-05	0.00454	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SREBF2—obesity	7.6e-05	0.00454	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SREBF2—obesity	7.33e-05	0.00437	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SREBF2—obesity	7.33e-05	0.00437	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MYOD1—obesity	7.33e-05	0.00437	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ANGPTL4—obesity	7.26e-05	0.00433	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PLIN1—obesity	7.26e-05	0.00433	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—AR—obesity	7.07e-05	0.00422	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SREBF1—obesity	7.04e-05	0.0042	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MYOD1—obesity	7.04e-05	0.0042	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MYOD1—obesity	7.04e-05	0.0042	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MYOD1—obesity	6.79e-05	0.00405	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MYOD1—obesity	6.79e-05	0.00405	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—PPARGC1A—obesity	6.66e-05	0.00398	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—GNB3—obesity	6.66e-05	0.00398	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—BDNF—obesity	6.48e-05	0.00386	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ADIPOQ—obesity	6.46e-05	0.00386	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—GCK—obesity	6.35e-05	0.00379	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IAPP—obesity	6.31e-05	0.00376	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL10—obesity	6.18e-05	0.00369	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FABP4—obesity	6.17e-05	0.00368	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SLC2A4—obesity	6.1e-05	0.00364	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—GCK—obesity	6.07e-05	0.00362	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IAPP—obesity	6.03e-05	0.0036	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—obesity	5.98e-05	0.00357	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—GCK—obesity	5.83e-05	0.00348	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—GCK—obesity	5.83e-05	0.00348	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NCOA1—obesity	5.82e-05	0.00347	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IAPP—obesity	5.8e-05	0.00346	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IAPP—obesity	5.8e-05	0.00346	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—obesity	5.72e-05	0.00341	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SREBF1—obesity	5.69e-05	0.0034	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—GCK—obesity	5.62e-05	0.00336	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—GCK—obesity	5.62e-05	0.00336	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IAPP—obesity	5.59e-05	0.00334	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IAPP—obesity	5.59e-05	0.00334	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—FOXO3—obesity	5.54e-05	0.0033	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PCK1—obesity	5.5e-05	0.00328	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—obesity	5.47e-05	0.00326	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SREBF1—obesity	5.45e-05	0.00325	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARGC1A—obesity	5.26e-05	0.00314	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SREBF1—obesity	5.23e-05	0.00312	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SREBF1—obesity	5.23e-05	0.00312	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ADIPOQ—obesity	5.23e-05	0.00312	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SREBF2—obesity	5.15e-05	0.00308	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SREBF1—obesity	5.04e-05	0.00301	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SREBF1—obesity	5.04e-05	0.00301	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ADIPOQ—obesity	5e-05	0.00298	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SLC2A4—obesity	4.94e-05	0.00295	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ADIPOQ—obesity	4.8e-05	0.00287	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ADIPOQ—obesity	4.8e-05	0.00287	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—LPL—obesity	4.79e-05	0.00286	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MYOD1—obesity	4.77e-05	0.00285	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—FOXO1—obesity	4.75e-05	0.00284	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SLC2A4—obesity	4.72e-05	0.00282	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NCOA1—obesity	4.71e-05	0.00281	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ADIPOQ—obesity	4.63e-05	0.00276	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ADIPOQ—obesity	4.63e-05	0.00276	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CD36—obesity	4.55e-05	0.00272	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SLC2A4—obesity	4.54e-05	0.00271	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SLC2A4—obesity	4.54e-05	0.00271	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NCOA1—obesity	4.5e-05	0.00269	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—FOXO3—obesity	4.48e-05	0.00267	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SLC2A4—obesity	4.37e-05	0.00261	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SLC2A4—obesity	4.37e-05	0.00261	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NCOA1—obesity	4.33e-05	0.00258	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NCOA1—obesity	4.33e-05	0.00258	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—TYK2—obesity	4.29e-05	0.00256	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—FOXO3—obesity	4.28e-05	0.00256	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—RHOA—obesity	4.26e-05	0.00254	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARGC1A—obesity	4.25e-05	0.00254	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARA—obesity	4.23e-05	0.00252	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NCOA1—obesity	4.17e-05	0.00249	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NCOA1—obesity	4.17e-05	0.00249	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—FOXO3—obesity	4.12e-05	0.00246	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—FOXO3—obesity	4.12e-05	0.00246	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARGC1A—obesity	4.07e-05	0.00243	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—LEP—obesity	4.01e-05	0.0024	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—FOXO3—obesity	3.97e-05	0.00237	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—FOXO3—obesity	3.97e-05	0.00237	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—GCK—obesity	3.95e-05	0.00236	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IAPP—obesity	3.93e-05	0.00234	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARGC1A—obesity	3.91e-05	0.00233	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARGC1A—obesity	3.91e-05	0.00233	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—LPL—obesity	3.87e-05	0.00231	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—FOXO1—obesity	3.85e-05	0.00229	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARGC1A—obesity	3.77e-05	0.00225	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARGC1A—obesity	3.77e-05	0.00225	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—LPL—obesity	3.7e-05	0.00221	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CD36—obesity	3.68e-05	0.0022	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—FOXO1—obesity	3.68e-05	0.00219	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—LPL—obesity	3.56e-05	0.00212	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—LPL—obesity	3.56e-05	0.00212	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SREBF1—obesity	3.55e-05	0.00212	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—FOXO1—obesity	3.53e-05	0.00211	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—FOXO1—obesity	3.53e-05	0.00211	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CD36—obesity	3.52e-05	0.0021	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARG—obesity	3.5e-05	0.00209	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—TYK2—obesity	3.47e-05	0.00207	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—RHOA—obesity	3.44e-05	0.00206	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LPL—obesity	3.43e-05	0.00205	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LPL—obesity	3.43e-05	0.00205	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—INS—obesity	3.43e-05	0.00205	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARA—obesity	3.42e-05	0.00204	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—FOXO1—obesity	3.41e-05	0.00203	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—FOXO1—obesity	3.41e-05	0.00203	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CD36—obesity	3.38e-05	0.00202	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CD36—obesity	3.38e-05	0.00202	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MMP9—obesity	3.38e-05	0.00202	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—TYK2—obesity	3.32e-05	0.00198	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT2—obesity	3.31e-05	0.00198	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—RHOA—obesity	3.29e-05	0.00197	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARA—obesity	3.27e-05	0.00195	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CD36—obesity	3.26e-05	0.00195	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CD36—obesity	3.26e-05	0.00195	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ADIPOQ—obesity	3.26e-05	0.00194	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—LEP—obesity	3.25e-05	0.00194	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL1B—obesity	3.24e-05	0.00193	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—TYK2—obesity	3.19e-05	0.0019	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—TYK2—obesity	3.19e-05	0.0019	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—RHOA—obesity	3.16e-05	0.00189	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—RHOA—obesity	3.16e-05	0.00189	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARA—obesity	3.14e-05	0.00188	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARA—obesity	3.14e-05	0.00188	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—LEP—obesity	3.11e-05	0.00185	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—TYK2—obesity	3.08e-05	0.00184	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—TYK2—obesity	3.08e-05	0.00184	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SLC2A4—obesity	3.08e-05	0.00183	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TYK2—obesity	3.06e-05	0.00183	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—RHOA—obesity	3.05e-05	0.00182	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—RHOA—obesity	3.05e-05	0.00182	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—RHOA—obesity	3.04e-05	0.00181	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARA—obesity	3.03e-05	0.00181	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARA—obesity	3.03e-05	0.00181	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—LEP—obesity	2.98e-05	0.00178	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—LEP—obesity	2.98e-05	0.00178	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NCOA1—obesity	2.93e-05	0.00175	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LEP—obesity	2.88e-05	0.00172	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LEP—obesity	2.88e-05	0.00172	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARG—obesity	2.83e-05	0.00169	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FOXO3—obesity	2.79e-05	0.00166	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—INS—obesity	2.77e-05	0.00166	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP9—obesity	2.73e-05	0.00163	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARG—obesity	2.7e-05	0.00161	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT2—obesity	2.68e-05	0.0016	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—INS—obesity	2.65e-05	0.00158	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARGC1A—obesity	2.65e-05	0.00158	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP9—obesity	2.62e-05	0.00156	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARG—obesity	2.6e-05	0.00155	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARG—obesity	2.6e-05	0.00155	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT2—obesity	2.56e-05	0.00153	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—INS—obesity	2.55e-05	0.00152	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—INS—obesity	2.55e-05	0.00152	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP9—obesity	2.51e-05	0.0015	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP9—obesity	2.51e-05	0.0015	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARG—obesity	2.51e-05	0.0015	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARG—obesity	2.51e-05	0.0015	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TYK2—obesity	2.48e-05	0.00148	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT2—obesity	2.46e-05	0.00147	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT2—obesity	2.46e-05	0.00147	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—INS—obesity	2.46e-05	0.00147	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—INS—obesity	2.46e-05	0.00147	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—RHOA—obesity	2.46e-05	0.00147	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP9—obesity	2.42e-05	0.00145	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP9—obesity	2.42e-05	0.00145	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP9—obesity	2.41e-05	0.00144	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LPL—obesity	2.41e-05	0.00144	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FOXO1—obesity	2.4e-05	0.00143	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT2—obesity	2.38e-05	0.00142	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT2—obesity	2.38e-05	0.00142	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TYK2—obesity	2.37e-05	0.00141	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—obesity	2.35e-05	0.0014	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—RHOA—obesity	2.35e-05	0.0014	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CD36—obesity	2.29e-05	0.00137	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TYK2—obesity	2.28e-05	0.00136	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TYK2—obesity	2.28e-05	0.00136	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—RHOA—obesity	2.26e-05	0.00135	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—RHOA—obesity	2.26e-05	0.00135	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TYK2—obesity	2.2e-05	0.00131	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TYK2—obesity	2.2e-05	0.00131	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—RHOA—obesity	2.18e-05	0.0013	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—RHOA—obesity	2.18e-05	0.0013	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—TYK2—obesity	2.16e-05	0.00129	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—RHOA—obesity	2.15e-05	0.00128	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—STAT3—obesity	2.15e-05	0.00128	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARA—obesity	2.13e-05	0.00127	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—obesity	2.1e-05	0.00125	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LEP—obesity	2.02e-05	0.00121	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TGFB1—obesity	1.99e-05	0.00119	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP9—obesity	1.95e-05	0.00116	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—obesity	1.9e-05	0.00113	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP9—obesity	1.87e-05	0.00111	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TNF—obesity	1.86e-05	0.00111	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP9—obesity	1.79e-05	0.00107	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP9—obesity	1.79e-05	0.00107	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARG—obesity	1.76e-05	0.00105	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—STAT3—obesity	1.74e-05	0.00104	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP9—obesity	1.73e-05	0.00103	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP9—obesity	1.73e-05	0.00103	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—INS—obesity	1.73e-05	0.00103	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP9—obesity	1.7e-05	0.00102	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—obesity	1.7e-05	0.00101	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT2—obesity	1.67e-05	0.000997	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—STAT3—obesity	1.66e-05	0.00099	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—obesity	1.62e-05	0.000969	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TGFB1—obesity	1.61e-05	0.00096	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—STAT3—obesity	1.59e-05	0.000951	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—STAT3—obesity	1.59e-05	0.000951	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—obesity	1.56e-05	0.000931	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—obesity	1.56e-05	0.000931	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TYK2—obesity	1.54e-05	0.000921	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TGFB1—obesity	1.54e-05	0.000918	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—STAT3—obesity	1.54e-05	0.000917	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—STAT3—obesity	1.54e-05	0.000917	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—RHOA—obesity	1.53e-05	0.000914	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—obesity	1.5e-05	0.000898	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—obesity	1.5e-05	0.000898	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TNF—obesity	1.5e-05	0.000896	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—obesity	1.5e-05	0.000894	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TGFB1—obesity	1.48e-05	0.000882	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TGFB1—obesity	1.48e-05	0.000882	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TNF—obesity	1.44e-05	0.000857	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TGFB1—obesity	1.43e-05	0.00085	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TGFB1—obesity	1.43e-05	0.00085	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—obesity	1.38e-05	0.000825	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TNF—obesity	1.38e-05	0.000824	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TNF—obesity	1.38e-05	0.000824	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TNF—obesity	1.33e-05	0.000794	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TNF—obesity	1.33e-05	0.000794	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP9—obesity	1.22e-05	0.000725	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—obesity	1.21e-05	0.000723	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—obesity	1.16e-05	0.000692	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—obesity	1.12e-05	0.000667	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—obesity	1.11e-05	0.000665	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—obesity	1.11e-05	0.000665	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—STAT3—obesity	1.08e-05	0.000645	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—obesity	1.07e-05	0.000641	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—obesity	1.07e-05	0.000641	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—obesity	1.07e-05	0.000638	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—obesity	1.06e-05	0.000631	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—obesity	1.03e-05	0.000613	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—obesity	1.03e-05	0.000613	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TGFB1—obesity	1e-05	0.000598	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—obesity	9.91e-06	0.000591	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—obesity	9.91e-06	0.000591	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TNF—obesity	9.36e-06	0.000558	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—obesity	7.55e-06	0.000451	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—obesity	6.97e-06	0.000416	CbGpPWpGaD
